Antibiotic resistance and antibiotic development (Q80915499)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18353258%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

title

Antibiotic resistance and antibiotic development (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18353258%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

main subject

antibiotic resistance

1 reference

Brad Spellberg

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18353258%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

publication date

1 April 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18353258%20AND%20SRC:MED&resulttype=core&format=json

Lancet Infectious Diseases

4 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18353258%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18353258%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18353258%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

page(s)

211-2; author reply 212-4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18353258%20AND%20SRC:MED&resulttype=core&format=json

Will longer antimicrobial patents improve global public health?

4 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970048-3

7 January 2021

Anti-infective research and development--problems, challenges, and solutions

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970048-3

7 January 2021

Trends in antimicrobial drug development: implications for the future

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970048-3

7 January 2021

Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970048-3

7 January 2021

Humans as the world's greatest evolutionary force

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970048-3

7 January 2021

Resistance to antibiotics: are we in the post-antibiotic era?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970048-3

7 January 2021

Societal costs versus savings from wild-card patent extension legislation to spur critically needed antibiotic development

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970048-3

7 January 2021

The price of innovation: new estimates of drug development costs

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970048-3

7 January 2021

10.1016/S1473-3099(08)70048-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18353258%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1 reference